UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of Bulky Inguinal and Pelvic Lymph Nodes

Urologic clinics of North America, 2024-08, Vol.51 (3), p.335-345

2024

Volltextzugriff (PDF)

Reply to Alireza Ghoreifi and Hooman Djaladat’s Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6

European urology, 2023-08, Vol.84 (2), p.e55-e56

2023

Volltextzugriff (PDF)

Spatial clustering of CD68+ tumor associated macrophages with tumor cells is associated with worse overall survival in metastatic clear cell renal cell carcinoma

PloS one, 2021-04, Vol.16 (4), p.e0245415-e0245415

2021

Volltextzugriff (PDF)

The 12-CK Score: Global Measurement of Tertiary Lymphoid Structures

Frontiers in immunology, 2021-06, Vol.12, p.694079-694079

2021

Volltextzugriff (PDF)

Complete Response of Primary Penile Tumor With Induction Paclitaxel, Ifosfamide, and Cisplatin (TIP) Chemotherapy

Société internationale d'urologie journal, 2023-03, Vol.4 (2), p.150-152

2023

Volltextzugriff (PDF)

Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?

Frontiers in oncology, 2021-02, Vol.10, p.627025-627025

2021

Volltextzugriff (PDF)

Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension

Current oncology (Toronto), 2023-03, Vol.30 (3), p.3223-3231

2023

Volltextzugriff (PDF)

Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals

European urology open science (Online), 2023-04, Vol.50, p.43-46

2023

Volltextzugriff (PDF)

68 The prognostic and predictive implications of the 12-chemokine score in muslce invasive bladder cancer

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A41-A42

2020

Volltextzugriff (PDF)

Perinephric Hematoma Size is Independently Associated with the Need for Urological Intervention in Multisystem Blunt Renal Trauma

The Journal of urology, 2018-05, Vol.199 (5), p.1283-1288

2018

Volltextzugriff (PDF)

PD19-12 BURDEN OF ACUTE TOXICITIES ASSOCIATED WITH TOPICAL CHEMOTHERAPY FOR NON-INVASIVE PENILE SQUAMOUS CELL CARCINOMA

The Journal of urology, 2020-04, Vol.203, p.e386

2020

Volltextzugriff (PDF)

Disparities in uptake of new FDA-approved therapies for metastatic clear cell renal cell carcinoma

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.370-370

2024

Volltextzugriff (PDF)

MP03-16 FEASIBILITY, USABILITY AND UTILITY OF A REMOTE SYMPTOM ASSESSMENT TOOL AFTER RADICAL CYSTECTOMY

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

PD63-07 PERINEPHRIC HEMATOMA SIZE IS INDEPENDENTLY ASSOCIATED WITH THE NEED FOR UROLOGIC INTERVENTION IN BLUNT RENAL TRAUMA

The Journal of urology, 2017-04, Vol.197 (4), p.e1256-e1257

2017

Volltextzugriff (PDF)

MP28-03 CYTOREDUCTIVE NEPHRECTOMY FOLLOWING IMMUNE CHECKPOINT INHIBITORS IS SAFE AND FACILITATES TREATMENT FREE INTERVALS

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

PD24-01 THE SELECTION FOR CYTOREDUCTIVE NEPHRECTOMY (SCREEN) SCORE: SURGICAL RISK STRATIFICATION INTEGRATING RADIOGRAPHIC FEATURES

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

PD09-09 SURVIVAL BENEFITS OF ADJUVANT CHEMOTHERAPY FOR POSITIVE SOFT TISSUE SURGICAL MARGINS FOLLOWING RADICAL CYSTECTOMY IN BLADDER CANCER WITH EXTRAVESICAL EXTENSION

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

PD59-02 COMPLICATIONS, RECOVERY, AND PATIENT-REPORTED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

MP76-20 CLINICAL STAGE I PURE TESTICULAR TERATOMA IN ADULTS: PATTERNS OF CARE AND SURVIVAL OUTCOMES BY TREATMENT STRATEGY

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Volltextzugriff (PDF)

Tumor fraction and copy number burden from urinary cell-free tumor DNA (utDNA) to predict minimal residual disease prior to repeat-transurethral resection in high-risk non-muscle invasive bladder cancer (HR-NMIBC)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.4600-4600

2024

Volltextzugriff (PDF)

MP71-13 DELAYS IN INITIATING FIRST LINE BLADDER SPARING THERAPY PORTEND WORSE PROGRESSION-FREE SURVIVAL FOR BCG UNRESPONSIVE PATIENTS

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

Alterations in tumor immune microenvironment and progressive immune exhaustion with advancing penile squamous cell carcinoma using multiplex immunofluorescence and image analysis

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.9-9

2024

Volltextzugriff (PDF)

Contemporary management of renal trauma in Canada: A 10-year experience at a level 1 trauma centre

Canadian Urological Association journal, 2019-06, Vol.13 (6), p.E177-E182

2019

Volltextzugriff (PDF)

Leveraging innovative therapies with an evolving understanding of the molecular pathogenesis of penile squamous cell carcinoma

Urologic oncology, 2022-05, Vol.40 (5), p.173-178

2022

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(81)
Buchkapitel
(1)

Sprache

Englisch
(82)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Management of Bulky Inguinal and Pelvic Lymph Nodes

Reply to Alireza Ghoreifi and Hooman Djaladat’s Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6

Spatial clustering of CD68+ tumor associated macrophages with tumor cells is associated with worse overall survival in metastatic clear cell renal cell carcinoma

The 12-CK Score: Global Measurement of Tertiary Lymphoid Structures

Complete Response of Primary Penile Tumor With Induction Paclitaxel, Ifosfamide, and Cisplatin (TIP) Chemotherapy

Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?

Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension

Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals

Geospatial Cellular Distribution of Cancer-Associated Fibroblasts Significantly Impacts Clinical Outcomes in Metastatic Clear Cell Renal Cell Carcinoma

68 The prognostic and predictive implications of the 12-chemokine score in muslce invasive bladder cancer

Perinephric Hematoma Size is Independently Associated with the Need for Urological Intervention in Multisystem Blunt Renal Trauma

PD19-12 BURDEN OF ACUTE TOXICITIES ASSOCIATED WITH TOPICAL CHEMOTHERAPY FOR NON-INVASIVE PENILE SQUAMOUS CELL CARCINOMA

Disparities in uptake of new FDA-approved therapies for metastatic clear cell renal cell carcinoma

MP03-16 FEASIBILITY, USABILITY AND UTILITY OF A REMOTE SYMPTOM ASSESSMENT TOOL AFTER RADICAL CYSTECTOMY

PD63-07 PERINEPHRIC HEMATOMA SIZE IS INDEPENDENTLY ASSOCIATED WITH THE NEED FOR UROLOGIC INTERVENTION IN BLUNT RENAL TRAUMA

MP28-03 CYTOREDUCTIVE NEPHRECTOMY FOLLOWING IMMUNE CHECKPOINT INHIBITORS IS SAFE AND FACILITATES TREATMENT FREE INTERVALS

PD24-01 THE SELECTION FOR CYTOREDUCTIVE NEPHRECTOMY (SCREEN) SCORE: SURGICAL RISK STRATIFICATION INTEGRATING RADIOGRAPHIC FEATURES

PD09-09 SURVIVAL BENEFITS OF ADJUVANT CHEMOTHERAPY FOR POSITIVE SOFT TISSUE SURGICAL MARGINS FOLLOWING RADICAL CYSTECTOMY IN BLADDER CANCER WITH EXTRAVESICAL EXTENSION

PD59-02 COMPLICATIONS, RECOVERY, AND PATIENT-REPORTED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY

MP76-20 CLINICAL STAGE I PURE TESTICULAR TERATOMA IN ADULTS: PATTERNS OF CARE AND SURVIVAL OUTCOMES BY TREATMENT STRATEGY

Tumor fraction and copy number burden from urinary cell-free tumor DNA (utDNA) to predict minimal residual disease prior to repeat-transurethral resection in high-risk non-muscle invasive bladder cancer (HR-NMIBC)

MP71-13 DELAYS IN INITIATING FIRST LINE BLADDER SPARING THERAPY PORTEND WORSE PROGRESSION-FREE SURVIVAL FOR BCG UNRESPONSIVE PATIENTS

Alterations in tumor immune microenvironment and progressive immune exhaustion with advancing penile squamous cell carcinoma using multiplex immunofluorescence and image analysis

Contemporary management of renal trauma in Canada: A 10-year experience at a level 1 trauma centre

Leveraging innovative therapies with an evolving understanding of the molecular pathogenesis of penile squamous cell carcinoma

Suchergebnisse filtern